Revenue: US$84.5m (down 55% from 3Q 2023). Net loss: US$121.3m (loss narrowed by 7.2% from 3Q 2023). US$0.76 loss per share ...

BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...

Analyst Alec Stranahan of Bank of America Securities reiterated a Hold rating on Novavax (NVAX – Research Report), reducing the price ...

Some analysts have estimated the market could be worth as much as $150 billion by the early 2030s. U.S-based Catalent, one of ...

Novavax Inc. closed $15.40 short of its 52-week high ($23.86), which the company achieved on June 6th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated ...

SIOUX CITY, Iowa (KCAU) — Meet today’s Stray of the Day: Alfie. Alfie is a one-to-two-year-old male, short-hair, brown tabby ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

The vaccine maker posted a narrower third-quarter loss than expected at 76 cents a share. Revenue was $85 million, compared ...

Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual ... the news and media division of Thomson Reuters, is the ...

More doctors are looking out for the condition. But that’s not enough to explain the increase in the nation’s overall ...

Arsenal, Los Angeles Rams, Denver Nuggets, and Colorado Avalanche - join forces to launch the “Green Action League,” the largest fan-driven campaign on sustainability ever seen in sports.

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...